Generating demand for mind-enhancing drugs

From Slashdot | Cosmetic Neurology

PR footwork for Big Pharma?Score:5, Insightful)

by openfrog (897716) on Sunday April 26, @05:42PM (#27723955)

There have been a few pieces of that kind in recent months, among those one in The Economist. They all follow the very same scenario and use the same rhetoric. Comments from readers testified of few benefits (confusion and excitation rather than concentration) and dramatic, often tragic side effects, with dependency consequences, etc. Each time the piece resurfaces, none of the downsides are mentioned and the same rhetoric: benign use, everybody uses it, unquestioned efficiency is brought back. Deregulating the sale of those drugs seems to be a coveted objective of Big Pharma and no wonder, considering the fabulous sums involved. Soma anyone?

[Slashdot] [Digg] [Reddit] [del.icio.us] [Facebook] [Technorati] [Google] [StumbleUpon]

Comments are closed.